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Summary 
The role of endothelial cells  (EC) in initiating a primary T  cell response is of importance in 
clinical transplantation and autoimmunity since EC are the first allogeneic target encountered 
by the recipient's immune system and may display tissue-specific autoantigens in the context of 
an inflammatory response. In this study, we have investigated the antigen-presenting cell func- 
tion of human umbilical vein-derived EC (HUVEC), depleted of constitutively major histo- 
compatibility complex class II + cells and induced to express class II molecules by interferon-~. 
The results show that HUVEC do not express B7 but can support proliferation by antigen-spe- 
cific T  cell clones. In contrast, they were unable to initiate a primary alloresponse using three 
independent HUVEC cultures and MHC class II-mismatched CD4 + T  cells from eight do- 
nors. The response to HUVEC was reconstituted by trans-costimulation  provided by DAP.3 
transfectants expressing human B7.1. Coculture of peripheral blood T cells with EC expressing 
allogeneic DR molecules had markedly different effects on CD45RO + and RA + subsets.  Sub- 
sequent reactivity of the R`O + T  cells was unaffected by exposure to EC, indicating a neutral 
encounter. In contrast, culture with DR. + EC induced allospecific nonresponsiveness in R_A  + 
T  cells. 
I 
nduction of  proliferation by naive CD4 + T  cells involves 
the delivery by the APC of at least two independent sig- 
nals.  The first signal  results  from the  engagement  of the 
TCR`/CD3/CD4  complex, and the second from the inter- 
action of CD28/CTLA-4 with the B7 family of costimula- 
tory molecules expressed by the APC. The cells that are most 
efficient in providing both signals are the so-called "profes- 
sional" APC.  Preeminent among these are dendritic cells; 
macrophages and activated B cells may also be able to pro- 
voke primary T  cell responses under some circumstances. 
Activation of  secondary T cell responses has also been shown 
to require B7-mediated costimulation, although this appears 
not to apply to all T  cells (Hargreaves, R.E.G. and Lechler, 
R.I., manuscript in preparation). Furthermore, antigen pre- 
sentation  by APC  that  cannot  provide costimulation  has 
been observed to render the Ag-specific T  cells refractory 
to a subsequent challenge, as far as IL-2 production is con- 
cerned (1-3). This type of"nonprofessional" APC is repre- 
sented by cells on which expression of MHC class II mole- 
cules can be induced by IFN-~/, such as keratinocytes (4, 
5), myoblasts (6), and thyroid follicular cells (Lombardi, G., 
unpublished observation). Siimlar results have been achieved 
using  cells  in  which  expression of class II  molecules has 
been engineered by transfection or by transgenesis (7, 8). In 
this context, the consequences of antigen presentation by 
endothelial cells (EC) 1, is open to question. 
The properties of EC as APC are likely to be important 
during local inflammatory responses and after transplanta- 
tion  of vascularized  tissues.  EC  are  the  first  alloantigen- 
expressing cells encountered by the recipient's immune sys- 
tem  after  transplantation,  and  human  capillary EC  have 
been  shown  to  express  MHC  class  II  molecules  in  the 
heart, kidney, and liver (9-11). Also, because of their wide- 
spread distribution throughout the body, EC are continu- 
ously encountered by circulating T  cells.  If EC are able to 
induce primary T  cell responses, this could create problems 
in the regulation ofautoimmune reactivity. The capacity of 
EC to reactivate previously activated T  cells is also of rele- 
vance to the effects of T  cell trans-migration  through EC 
monolayers at the sites of  local inflammation. 
The conclusions from previous studies suggest that EC 
can support mitogen-induced T  cell proliferation (12),  an- 
1Abbreviations used in this paper: B-LCL,  EBV-transforrned  B-lymphoblas- 
toid cell lines; EC; endothelial ceils; HA, hernagglutinin; HLA, human 
leukocyte antigen; HS, human serum; HUVEC, human umbilical vein- 
derived  EC; TdR, thymidine. 
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sponses (14-16). 
In this study, we have investigated the APC function of 
human EC, depleted of conventional APC, and induced to 
express MHC  class II molecules by treatment with IFN-% 
The results obtained show that human EC lack the expres- 
sion of B7 family of molecules, but can support proliferation 
of T  cell clones when costimulation mediated by B7 mole- 
cules is not required. On the contrary, they were unable to 
initiate a primary alloresponse by resting CD4 § T  cells. Fur- 
thermore,  recognition of alloantigen on EC by the CD45 
RA +  subpopulation of peripheral blood T  cells induced a 
state of allospecific unresponsiveness. 
Materials and Methods 
Antigens and Miwgens.  The synthetic hemagglutinin (HA) pep- 
tide HA 307-319  was  synthesized by the  Imperial Cancer Re- 
search Fund Peptide Unit (London) and kindly provided by Dr. H. 
Stauss (ICRF, London,  U.K.).  PHA was  purchased from  Sigma 
Chemical Company Ltd. (Poole, Dorset, UK). 
mAbs.  The following mAbs were used for staining cells for 
flow cytometric analysis as hybridoma supernatants: anti-B7/BB1 
(anti-B7.1; Becton Dickinson, Cowley, Oxford, UK), BB1  (anti- 
B7.1;  kindly provided  by J.  Ledbetter,  Bristol-Myers Squibb, 
Seattle, WA)  (17),  and L243  (anti-HLA DRe(; American Type 
Culture  Collection  [ATCC],  Rockville,  MD).  The  following 
Abs were used in purified form for preparation of human umbili- 
cal vein--derived  ECs (HUVECs) and CD4 + T cells: Leu 19 (anti- 
CD56;  Becton Dickinson), mouse anti-human Ig (Fab specific; 
Sigma), OKT8 (anti-human CD8; ATCC), and L243. The OKT8 
and L243  mAbs were purified from the  culture supernatant on 
protein A-Sepharose beads by standard methods. Eluted antibody 
was dialyzed against three changes of PBS. 
The fusion protein CTLA-4-Ig obtained from supematant of 
COS transfectants (gift from P. Lane, Basel Institute for Immu- 
nology,  Basel,  Switzerland)  (18),  and  the  mAb  TS  2.9  (anti- 
human LFA-3; ATCC), anti-DP (B7.21;  ATCC), and anti-DQ 
(L2,  19)  were  purified  as  described  above.  The  mAbs  anti- 
CD45RO (UCHL1; gift from P. Beverley, [CRF) (20), and anti- 
CD45RA  (SN  130;  gift from G. Janossy, Royal Free Hospital, 
London) (21), were purified as described above and used for iso- 
lation of CD4 T cell subsets. 
Separation and Culture of HUVECs.  HUVEC were isolated from 
human umbilical cord veins by collagenase (Sigma) treatment ac- 
cording to a modification of the technique described by Jaffe  et 
al. (22), and were depleted of contaminating MHC II  + cells using 
the Dynabead technique (Dynal Ltd., Merseyside, UK) according 
to the manufacturer's instructions. 
Recovered  cells were  serially subcultured  at  37~  with  5% 
CO 2 in Medium 199  (Sigma) supplemented with 20% heat-inac- 
tivated FCS, 2 mM glutamine (Flow Laboratories, Irvine, UK), 
150 Ixg/ml Endothelial Cell Growth Supplement (Sigma), 12 U/ml 
heparin (Sigma),  100 U/ml penicillin (Flow), 100 Ixg/ml strepto- 
mycin (Flow), and 2.5 txg/ml Fungizone (ICN Biomedicals Inc., 
Costa Mesa,  CA)  in tissue  culture flasks  (Greiner Labortechnik 
Ltd., Dursley, UK) coated with gelatin (Sigma). 
At confluence, HUVEC were detached from the culture flasks 
using a solution of 0.125% trypsin in 0.2% EDTA (Life Technol- 
ogies Ltd., Paisley, UK) and passaged. 
For functional assays, HUVEC were used in the assays at pas- 
sage 4-10. 
Cell Lines.  The DAP.3-B7 cell line was generated by trans- 
fecting murine DAP.3 cells with a cDNA clone encoding human 
B7.1  in  the pcExV-3 vector (a kind giK from Dr.  M. Jenkins, 
University of Minnesota, Minneapolis, MN) with pHyg, which 
contains a hygromicin B-resistance gene at ratios of 100:1,  50:1, 
and 20:1.  Ceils expressing the transfected gene were selected in 
medium containing 200  Ixg/ml hygromicin B  (Sigma).  The fi- 
broblast line was cultured in DMEM tissue culture medium (Flow 
Laboratories, Irvine, Ayrshire, Scotland) supplemented with 10% 
FCS, 2 mM glutamine, 50 IU/ml penicillin, and 50 ~g/ml strep- 
tomycin. 
EBV-transformed B-lymphoblastoid cell lines (B-LCL), from 
the 10th International Histocompatibility  Workshop (Princeton, NJ 
and New York, November, 1987),  were cultured in RPMI 1640 
tissue culture medium (Flow) supplemented with 10% FCS, 2 mM 
glutamine, 50 IU/ml penicillin, and 50 I~g/ml streptomycin. 
Purification of CD4  + T  Cells.  PBMC were obtained by Ficoll- 
Hypaque (Pharmacia)  centrifugation of heparinized blood, washed 
twice,  and resuspended in  RPMI  1640  medium supplemented 
with  10%  FCS, 2  mM  glutamine, 50  IU/ml penicillin, and 50 
txg/ml streptomycin. The  cell preparation was then depleted of 
adherent cells by two 45-rain rounds of adherence to plastic on 
tissue  culture dishes at 37~  The nonadherent cells were subse- 
quently collected and incubated with a cocktail of purified mAbs 
(L243,  OKT8,  Leul9,  and mouse  anti-human  Ig)  at saturating 
condition for 30 rain at 4~  The cells were then washed twice to 
remove excess antibody and further enriched by magnetic immu- 
nodepletion. Briefly, mAb-treated cells were incubated with mag- 
netic  microbeads  (Miltenyi Biotec  GmbH,  Bergisch  Gladbach, 
Germany) coated with sheep anti-mouse Ig for  15  min at 4~ 
and bead/mAb-coated cells were removed by passage through a 
magnetic column (miniMAC system; Miltenyi). The purified cells 
were  resuspended in medium  ready for the  proliferation assay, 
and accessory cell contamination assessed by culture with 2 Ixg/ml 
PHA in a 48-h assay. 
T  Cell Clones.  Clones 7P.13, 7P.26, 7P.62, 7P.66, and 7P.69, 
specific for HA 307-319, were derived from PBMC isolated from 
a  DRBI*0701  individual as  described previously  (5,  6).  The 
clones were maintained in culture by weekly stimulation with au- 
tologous PBMC, HA peptide, and rlL-2 (Boehringer Mannheim 
Biochemicals, Mannheim, Germany) in RPMI 1640 medium sup- 
plemented with 10% human serum (HS), 2 mM glutamine, 50 IU/ 
ml  penicillin, and  50  I.Lg/ml streptomycin.  For use  in  experi- 
ments, the T  ceils were purified by isolation on a Ficoll-Paque 
gradient 7  d  after restimulation and washed  five times by low 
speed centrifugation (210 g for 5 rain) before use. 
Flow Cytofluorimetric Analysis.  For flow cytofluorimetric analysis, 
HUVEC  that  had been  previously detached by trypsin-EDTA 
treatment were fixed with 4%  paraformaldehyde in PBS  for 30 
rain at 4~  washed, and permeabilized with 0.1% saponin in PBS 
for 30 rain at 4~  The cells were subsequently stained with the 
indicated mAbs for 30 rain at 4~  After two further washes in 
PBS with 2%  FCS, the cells were incubated for 30 min at 4~ 
with 100 ILl of 1:50 dilution of fluoresceinated sheep anti-mouse 
Ig (Amersham International, Amersham,  UK).  After two  addi- 
tional washes, stained cells were analyzed using the EPICS Profile 
flow cytometer (Coulter Electronics, Luton, UK). 
For surface molecule staining (L243, B7, BB1, and CTLA-4-Ig), 
fixation and permeabilization steps were not performed. 
T  Cell Proliferation Assays.  T  cell clones (104 cells/well) were 
cultured in the presence of HUVEC (treated with 40 Gy X  irra- 
diation) or B-LCL (2 ￿  104 cells/well, treated with 120 Gy X ir- 
radiation) prepulsed with HA peptide for  16 h  in flat-bottomed 
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1640 medium supplemented with 10% HS, 2 mM glutamine, 50 
IU/ml penicillin,  and 50 I~g/ml streptomycin. 
After  48  h,  wells  were  pulsed  with  1  txCi  3H-Thymidine 
(TdK)  (Amersham),  and  harvested  onto  glass fiber filters  18  h 
later.  Proliferation  was  measured  as 3H-TdR  incorporation by 
liquid scintillation  spectroscopy. The results are  expressed  as the 
mean of triplicate  cultures.  SEs were routinely < 10%. 
For primary MLP~ assays, purified human CD4 + T  cells (105 
cells/well)  were cultured with different  numbers of either irradi- 
ated aUogeneic HUVEC, B-LCL, or PBMC at the numbers indi- 
cated in flat-bottomed plates (Flow) for 6 d. In some experiments, 
DAP.3 B7 transfectants pretreated with mitomycin C were added 
to the cultures.  Wells were pulsed  with  I  I~Ci 3H-TdR before 
the end of the culture. Proliferation was measured and expressed 
as described  above. 
Three Stage Cultures  for Tolerance  Induction.  Purified CD4 + T cells 
(106/well) were plated out in 24-well plates in the presence of 
allogeneic  IFN-~/-treated EC  (2  ￿  105/well)  with  or without 
DAP.3-B7  cells (1:l  ratio),  a  second  population  of allogeneic 
IFN-~/-treated EC  expressing  a  different  HLA-DK allele (2  ￿ 
10S/well), and B-LCL expressing  the same HLA-DR type as the 
first EC population (2  ￿  105/well).  After 5 d, the T  cells were 
harvested,  purified by isolation  on a Ficoll-Paque gradient,  and 
washed five times by low speed centrifugation (210 g for 5 min). 
Recovered T cells from each culture were subsequently restimu- 
lated  (2  ￿  104/well)  with each of the allogeneic  IFN-~-treated 
EC (2 ￿  10Vwell)  in the presence or absence of DAP.3-B7 cells 
(1:1 ratio),  the same B-LCL (2  ￿  104/well),  and a B-LCL ex- 
pressing the same HLA-DR allele as the second population of  EC 
(2  ￿  104/well).  In the rechallenge cultures  containing B-LCL, 
monoclonal anti-DP and anti-DQ antibodies  were added at a fi- 
nal  concentration of 2  Ixg/ml. After 3,  7, and  10 d,  cells were 
pulsed  with 1 txCi 3H-TdR. Prohferation was measured and ex- 
pressed as described  above. 
Results 
Characterization of HUVECs.  EC were obtained from four 
umbilical  cord veins.  Blood derived  from the  same  cords 
was used for HLA typing. Once isolated, the EC were de- 
pleted  of contaminating DR +  cells by magnetic bead im- 
munodepletion. No DR. + cells were detected by flow cyto- 
fluorimetric analysis ofpassaged EC (Fig.  1 a). 
To confirm their endothehal lineage, the cells were first 
stained using the anti-von Willebrand Factor (vWF) mAb, 
and were tested for acetylated LDL uptake. The cells were all 
positive for vWF and were able to take up acetylated LDL 
(data not shown). Before use in functional assays,  HUVEC 
were  treated  with  1,000  U/ml  IFN-~/ for 72  h.  The  ex- 
pression level  of MHC  class  II molecules  induced  on the 
HUVEC  was  comparable  to  that  of PBMC  and  B-LCL 
(Fig.  1, b-d). 
To test for expression  of the B7 family of costimulatory 
molecules,  EC were stained with the mAbs anti-B7/BB1, 
which binds to B7.1; BB1, which recognizes B7.1  and has 
been reported  to bind a third isoform of the B7 family of 
molecule (23); and the fusion molecule CTLA-4-Ig, which 
binds to all known isoforms of B7. As shown in Fig. 2, no 
expression  of any of these molecules could be detected on 
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Figure 1.  Expression  of  MHC class II molecules by IFN-~/-treated EC. 
EC were cultured in the absence (a) or in the presence (b) of IFN-',/(104 
U/ml) for 4 d. EC were then stained either with an irrelevant mAb (solid 
lines) or with anti-DR  mAb (dotted lines). The HLA-DR. expression of 
PBMC (c) and a B-LCL (d) are shown for comparison. 
HUVEC: in contrast, the B-LCL stained positively with all 
three  anti-B7  reagents.  The  staining  with  CTLA-4-Ig is 
shown in Fig. 1 d. Furthermore, B7 expression was not in- 
duced on the  EC,  neither by cytokine treatment  (IFN-~/, 
TNF-o~, and IL-4) nor by preincubation with PMA and/or 
ionomycin (data not shown). 
Antigen Presentation by IFN-T-treated EC Induced Prolifera- 
tion by B7-independent  T  Cell Clones.  The  antigen-present- 
ing function of HUVEC was first analyzed by testing their 
capacity to stimulate  the prohferation of a panel of five es- 
tabhshed T  cell clones, restricted by DR7, and specific for a 
defined peptide  (307-319)  of influenza  HA.  T  cells  were 
purified,  as  described in Materials  and Methods,  and their 
proliferation to IFN-~/-treated EC, or to B-LCL, prepulsed 
with different doses ofpeptide, was measured. All the T  cell 
clones  proliferated  to  the  peptide  presented  by  EC,  al- 
though  the  magnitude  of the  response  was  substantially 
lower  than  that  induced  by  the  B-LCL.  An  example  is 
shown in Fig. 3  a.  The proliferative response could be in- 
hibited by the  addition  of anti-DR  (L243)  or anti-LFA-3 
(TS  2.9)  mAbs to the  cultures,  but was unaffected by the 
presence of CTLA-4-Ig, suggesting that the interaction be- 
tween B7 and CD28/CTLA-4 was not necessary to induce 
antigen-specific activation of these clones. Confirmation of 
the  B7 independence  of these  T  cell clones was provided 
by showing that CTLA-4--Ig failed to inhibit proliferation 
induced by B-LCL prepulsed  with  optimal  or suboptimal 
doses ofpeptide (Fig. 3 b). 
The Capacity  of MHC  Class II-expressing  EC to Stimulate 
Primary Alloproliferation  by CD4 §  T  Cells Is Inversely  Corre- 
lated with the Purity of the Responder  T  Cells.  It has been re- 
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Figure  2.  HUVECs lack B7  expression. The  results of staining of 
HUVEC with three anti-B7 reagents, anti-B7.1, BBI, and CTLA-4-Ig 
(dotted line) and with an irrelevant  mAb  (solid line) are shown, respectively, 
in a, b, and c. In d, the staining  ofa B-LCL with CTLA-4-1g is shown for 
comparison. 
ported that B7-mediated costimulation is critical in the in- 
duction of a primary alloresponse by CD4  + T  cells (8,  24, 
25). In this context, the ability ofallogeneic IFN-~/-treated 
EC  to  induce primary alloproliferation by highly purified 
resting CD4 §  T  cells from several human leukocyte anti- 
gen  (HLA)-mismatched donors  was  examined.  CD4  +  T 
cells  were  unable to  proliferate  to  allogeneic  EC,  while 
they were strongly responsive to B-LCL and to PBMC ex- 
pressing the  same  HLA-DP, type  as  the  EC.  The  results 
from one of these experiments are shown in Fig. 4  a.  To 
test the possibihty that the failure of EC to stimulate a pri- 
mary alloresponse was caused by the lack of B7 expression, 
CD4 § T  cells were cocultured with EC in the presence of 
a murine fibroblast cell hne transfected with a cDNA clone 
encoding human B7.1  (DAP.3-B7). As shown in Fig. 4  b, 
the  addition of DAP.3-B7  reconstituted  the  response  of 
CD4 + T  cells to EC, by providing trans  costimulation. The 
reconstitution was completely abrogated by the addition of 
CTLA-4--Ig. The purity of the responder T  cell population 
appeared to be inversely correlated with the primary allo- 
proliferative response to EC.  This is illustrated by the data 
shown in Fig. 5.  In these experiments, increasing numbers 
of purified CD4 + T  cells (up to 3  ￿  10S/well, the highest 
number of responder  cells  used  in previous studies  [15]) 
were cultured with 2  ￿  104 stimulator cells (IFN-~/-treated 
or untreated EC, as well as B-LCL). In the first experiment 
(Fig. 5 a), a significant response to MHC class II-expressing 
EC  was  observed at  the  highest  responder cell numbers. 
Frozen T  cells, stored from the same cell preparation, were 
then thawed, repurified, and used in an identical prolifera- 
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Figure  3.  EC  can stimulate antigen-specific  T  cell clones. IFN-'y- 
treated EC (open  circles) and B-LCL (open  squares)  were pulsed overnight 
with  different doses of peptides. 104/well HA  307-319~pecific and 
DR7-restricted T  cell clones were cultured with either 2 ￿  104/well 
prepulsed EC or B-LCL (upper panel).  The plates were incubated for 3 d 
and 3H-TdR was added for the last 18 h. Results are expressed as the 
mean cpm for triplicate cultures X  10 -3. T cell proliferation  was inhibited 
by the addition  of anti-DR (solid circles) or anti-LFA3  (solid triangles), but not 
by CTLA-4-Ig (solid squares).  Proliferation  by the T cell clone  to B-LCL 
prepulsed with suboptimal (0.3 p~g/ml) or optimal (1  p~g/ml) doses of 
peptide was inhibited by the addition of anti-DR mAb (1  ~g/ml), but 
not by CTLA-4-Ig (1 p~g/ml). 
tion assay (Fig. 5 b). After this second round ofT cell puri- 
fication,  the  previously observed proliferative response  to 
IFN-',/-treated EC disappeared, even at high responder cell 
numbers, while the response to the B-LCL was slightly in- 
creased. 
A summary of 10 experiments using 8 different responder/ 
stimulator combinations is shown in Table 1, in which the 
responses of purified CD4 +  T  cells to  allogeneic IFN-~/- 
treated EC,  untreated EC,  PBMC,  and B-LCL  are  com- 
pared. The proliferation to PHA (2  b~g/ml) by PBMC and 
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Figure 4.  EC are unable to stimulate a primary MLR. CD4 + T cells 
from a DR15/DR7 heterozygous individual were purified as described in 
Materials and Methods. CD4 + T cells (105 cells/well) were cultured with 
different numbers of HLA-DRB1*1701 expressing B-LCL (solid drcles), 
PBMC (solid squares), and EC pretreated with IFN-~/(104 U/ml) (open cir- 
cles). The results are shown in the upper panel. In the lower panel, CD4 + 
T  cells were  cultured  either  with  EC  alone  (open circles) or with  the 
DAP.3 cell line expressing B7 (open squares). In addition, CD4 + T cells 
were cocultured with EC and DAP.3-B7 cells in the absence (solid circles) 
or in the presence (solid squares) of CTLA-4-Ig. The plates were incu- 
bated for 5 d and 3H-TdR was added for the last 18 h. Results are ex- 
pressed as the mean cpm for triplicate cultures ￿  10 -3, corrected for back- 
ground proliferation of both T cells and stimulators alone (A cpm). SEs 
were routinely <10%. 
purified CD4 +  T  cells is also shown.  Notably, in the two 
experiments in which significant prohferative responses to 
allogeneic IFN-T-treated EC could be detected, the PHA 
responses of the purified CD4 + T  cells were also high. This 
was indicative of the presence of contaminating autologous 
APCs in the T  cell populations in these two experiments. 
It  has  been  suggested  that  the  CD45RO +  subset  of 
CD4 +  T  cells is  more  efficiently stimulated by EC  than 
the CD45RA +  subset  (25).  The  proliferation of separated 
CD45RO + and CD45RA + T  cell subpopulations to HLA- 
DR-expressing allogeneic EC was compared. Neither sub- 
set  proliferated  to  the  EC,  while  a  strong  response  to 
B-LCL was observed (Fig. 6  a). Taken together, these data 
suggest that the ability of EC to stimulate a primary MLR 
is  correlated  with  the  presence  of contaminating  autolo- 
gous APC in the responder T  cell population. 
CD4 +  CD45RO  §  Resting  T  Cells were Neither  "Primed" 
Nor  "Anergized"  by  Coculture  with  IFN-y-treated  Allogeneic 
EC.  It has previously been  shown  that specific recogni- 
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tion in the absence of B7-mediated costimulation can lead 
to a  state of nonresponsiveness in T  cell clones. Work by 
Tan  and  colleagues  (27)  showed  that  in  a  unidirectional 
primary MLR,  responding T  cells can be rendered refrac- 
tory  to  a  subsequent  challenge  with  the  same  stimulator 
cells by the presence of CTLA-4-Ig in the primary cultures. 
In  a  primary  MLR  model  by  Boussiotis  and  colleagues 
(25), murine cells transfected with human HLA-DR  mole- 
cules induced alloantigen-specific anergy in purified CD4 + 
T  cells, and cotransfection of human B7 in the same stimu- 
lator cells resulted in their ability to costimulate prolifera- 
tion of the alloreactive T  cells. It has also been shown that 
both  memory and  naive T  cells require  two  signals to be 
activated, although naive T  cells have a higher threshold for 
both signals (28). We reasoned that this quantitative differ- 
ence  might be reflected in a  different susceptibility to  the 
induction of unresponsiveness. This possibility was examined 
in a three-step culture model. Purified CD4 + T  cell subsets 
were cocultured with two populations ofallogeneic IFN-y- 
treated EC and a B-LCL expressing the same HLA-DR. al- 
leles as the first population of EC.  The  results of a  simple 
proliferation assay, performed in parallel with the primary 
cocultures, is shown in Fig. 6 a. After 5 d, the T  cells were 
harvested and purified as described in Materials and Meth- 
ods.  T  cells from  each  culture  were  subsequently  rechal- 
lenged in a proliferation assay with both populations of al- 
logeneic IFN-~/-treated EC in the presence or absence of 
DAP.3-B7 cells, the same B-LCL, and a second B-LCL ex- 
pressing the same HLA-DR  allele as the second population 
of EC.  A  representative example  of a  series of criss-cross 
experiments is shown  in Fig. 6  b.  CD45RO +  T  cells that 
had been cocultured with IFN-~-treated EC were still able 
to  respond  to  EC  plus  DAP.3-B7  or B-LCL  (expressing 
the  same DR  as the EC),  but were  not  "primed" in that 
the proliferative response had a primary kinetic (peak of re- 
sponse after 7-10 d; Fig. 6 b, i and i0. T  cells previously co- 
cultured with B-LCL were  "primed," and responded with 
a secondary kinetic to EC and to the same B-LCL used for 
priming (peak of response after 3 d; Fig. 6  b, iiO. 
Coculture of CD4 + CD45RA  + T  Cells with IFN-y--treated 
Allogeneic EC-induced  Allospecific Nonresponsiveness.  In  con- 
trast with  the  results  obtained with  CD4 +  CD45RO +  T 
cells, after being cultured in the presence of MHC  class II- 
expressing EC,  CD45RA +  T  cells lost  the  ability to  re- 
spond to the same allogeneic EC in the presence of the B7- 
transfected DAP.3 cells. The response to B-LCL expressing 
the same DR  type as the EC  was  also severely depressed, 
while  the  T  cells retained the  capability of responding to 
other IFN-y-treated EC in the presence of B7-transfected 
cells and to another B-LCL (Fig. 6 c, i and i O. As previously 
shown  for the  CD45RO +  subset,  the  CD45RA +  T  cells 
were  primed  after  their  culture  with  B-LCL  and  prolif- 
erated with a peak of response at day 3 to both EC and B- 
LCL expressing the same HLA-DR  molecule as the B-LCL 
used for the priming (Fig. 6 c, iiO.  Anti-DP and -DQ mAbs 
were included in the rechallenge cultures containing B-LCL 
to  exclude possible effects of DP  and DQ  differences be- 
tween the EC and the B-LCL. a 
300. 
2oo 
IOO 
b 
300 
B-LCL 
EC-T  i 
~  ~~E  C- NT ii 
0  i0  2  30  0 
200 
100 
gC-T  1  ii 
---"~  EC-NT 
1 
10  2~)  30 
AW  CD4 + T cells  x I0  -4 
Figure  5.  The primary alloprolif- 
erative response  to  MHC  class lI- 
expressing EC is inversely correlated 
with  the  purity  of  the  responder 
CD4 +  T  cell  population.  CD4 + T 
cells  from  a  DR4/15  heterozygous 
individual (AW) were purified as de- 
scribed  in  Materials  and  Methods. 
Increasing numbers of CD4 + T  cells 
were cultured with 2  ￿  104 HLA- 
DRBl*1701  expressing  B-LCL 
(solid  circles), EC  pretreated  with 
IFN-~/  (104 U/ml) (open circles), and 
untreated EC (open squares). In a, the 
results of an assay after a poor CD4 § 
T cell enrichment (response of 10  s T 
cells to 2 p~g/ml PHA =  35.1  ￿  103 
cpm) are shown, Frozen T cells from 
the  same  preparation  were  then 
thawed,  repurified  afier  the  same 
procedure  and used in an identical 
primary MLP. assay. The results are shown in b (response to PHA after the second purification =  22.0 ￿  103 cpm). The plates were incubated for 5 d, 
and 3H-TdR. was added for the last 18 h. Results are expressed as the mean cpm for triplicate  cultures  ￿  10 -3, corrected for background proliferation of 
both T cells and stimulators alone (A cpm). SEs were routinely <10%. **, IFN-'?-treated EC; *NT, non-IFN-"/-treated EC. 
In  the  Presence  of  B7  trans  Costimulation,  Cocuhure  of 
CD45RO + and CD45RA + T  Cells with IFN-T-treated AUo- 
geneic EC Led to Allospecific Priming.  In previously  described 
culture models,  in which  T  cell nonresponsiveness was  in- 
duced by  cognate  interactions with  costimulation-deficent 
stimulators,  the T  cells could be protected from the induc- 
tion  of nonresponsiveness  by  providing B7-mediated  co- 
stimulation  (8).  This possibility was tested by coculturing 
CD45RO +  and  CD45R.A +  T  cell  subsets  with  IFN-'y- 
treated  EC  in  the  presence  of B7-transfected  cells.  As  is 
shown in Fig.  7, a and b, both T  cell subsets were primed 
by EC in the presence of B7-mediated costimulation sup- 
plied in the form of  B7 transfectants, and they responded to 
a rechaUenge with the same EC plus DAP.B7 with a sec- 
Table  1.  IFN-'y-treated EC Fail to Induce Primary Alloresponses by CD4 + T Cells 
Stimulator cells used 
Response to PHA 
(2 ~g/ml) 
Exp.  Comb.*  EC-T*  EC-NT*  PBMC-~  B-LCL~  T  CD4 +LI  PBMCII 
17.2.94  FM/EC F5  0.7  ND  21.8  63.9  25.0  125.9 
17.2.94  P,G/EC F5  0.6  ND  7.9  52.5  20.3  99.8 
31.3.94  P-G/EC F4  1.1  ND  26.0  89.0  15.2  89.0 
11.7.94  AW/EC  F4  5.9  6.2  43.1  214.7  35,1  105.6 
17.7.94  AW/EC  F4  2.6  2.9  50.7  186.4  22.0  112.4 
14.7.94  kH/EC  F3  1.5  1.4  94.0  252.2  12.0  ND 
20.7.94  P,H/EC F4  1.3  1.4  132.9  301.4  10.0  98.1 
12.8.94  FM/EC F2  15.5  1.7  93.2  275.9  37.9  102.3 
12.%94  RH/EC  F4  0.2  0.2  ND  189.1  19.4  103.5 
23.11.94  P,L/EC  F3  3.3  5.3  47.8  110.0  16.8  89.4 
Summary of 10 experiments using 8 different combinations showing the proliferative responses of purified CD4 + T cells (10S/well to 2 ￿  104 allo- 
geneic IFN-3~-treated EC (column 3), untreated EC (column 4), PBMC (column 5), and B-LCL (column 6). In the last two columns, the prohfer- 
ative responses of 10  s purified CD4 § T  cells and PBMC to PHA (2 p.g/ml) are shown, kesults are expressed as the mean cpm for triplicate culture 
X 10  -3, corrected for background prohferation of both T  cells and stimulators alone (A cpm). SEs were routinely <10%. 
*  R.esponder/stimulator combination. 
*EC treated (T) or not treated (NT) with IFN-~I. 
~Allogeneic  PBMC and B-LCL expressing the same DR alleles as the EC. 
IIProliferative responses to PHA by 10  s CD4 § T  cells after purification and 105 PBMC before purification. 
1608  Endothelial Cells Induce Allospecific Nonresponsiveness ondary  kinetic.  Furthermore,  CD45RA  +  T  cells  cocul- 
tured with IFN-'?-treated  EC  in the presence of anti-DR 
mAb  remained capable of responding to a subsequent stim- 
ulation with the same EC  and B7-transfected cells without 
being primed  (Fig.  7  c).  This demonstrates that the induc- 
tion  of the  allospecific  nonresponsiveness  was  stricdy  de- 
pendent  on the  engagement  of the T  cell receptor by the 
allogeneic  HLA-DR  molecules  on  the EC  in the  absence 
of costimulafion. 
Discussion 
In  this  study,  the  antigen-presenting  cell  function  of 
HUVEC  induced  to  express  MHC  class  II  molecules  by 
IFN-~/  treatment  was  investigated.  The  results  obtained 
showed  that EC  can be competent  APC  for human  T  cell 
clones,  but  are  unable  to  induce  primary  alloreacdve  re- 
20- 
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T ceils 
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q~"'EC2§ 
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Figm~ 6.  Antigen recognition on EC by CD45RA  + T  cells renders 
them unresponsive to a subsequent rechaUenge.  (a) Alloproliferation of 
fireshly purified CD45KO + and CD45KA  + CD4 + T  cells to HUVEC 
and B-LCL during the first step of the tolerance induction experiments. T 
cells (104/well)  from either of the two  subsets responded to allogeneic 
B-LCL (104/well), but not to HUVEC (1(P/well), unless tram costimula- 
don was provided by the addition of DAP.3-B7 cells (1:1 ratio).  (b and c) 
Purified CD4 + T  ceil subsets, CD45RO + (b) and CD45RA + (c), were 
cocukured with allogeneic IFN-'y-treated EC  I  (DILl7), EC 2  (DRT/ 
DR13), and B-LCL 1 (expressing the same HLA DIL as the EC 1), as de- 
scribed m Materials and Methods. T cells from each culture were subse- 
quently rechallenged m a proliferation assay with EC 1 (104/well) and EC 
2 (10Vwell) m the presence of DAP.3-B7 (1:1 rado) ceils, B-LCL l  (t04/ 
well),  and B-LCL 2  (DR7) (104/well).  In the rechaltenge cultures con- 
raining B-LCL, the B7.21 (anti-DP) and L2 (anti-DO.) mAhs were added 
to exclude any effect of mismatching between the EC and the B-LCL at 
these loci.  Rechallenge cultures were harvested on days 3, 7, and 10 to 
detect  responses  with  prmtary versus  secondary  kinetics?H-TdP,  was 
added for the last 18 h. Results are expressed as the mean cpm for tripli- 
cate cultures X 10 -3,  corrected for background proliferation of both T 
cells and stimulators  alone (A cpm). SEs were routinely <10~  The re- 
sponder and stimulator cells present in the imtial culture are indicated 
above each pair of graphs.  The stimulator cells used in the rechallenge 
step are indicated within each graph. 
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Figure 7.  Delivery of B7-mediated costimulation results in "priming" 
of  both T cell subsets  and blockade  of  cognate interaction  rescues CD45RA + 
T  cells from  the  induction  of allospecific nonresponsiveness. Purified 
CD4 § T cell subsets, CD45RO + (a) and CD45RA + (b), were cocultured 
with allogeneic IFN-~/-treated EC 1 (DR17) in the absence or presence 
of B7-transfected  cells, as  described  in  Materials and  Methods.  (c) 
CD45RA + T cells  were cultured with EC 2 in the absence or presence of 
L243 (1 I~g/ml). T cells from each culture (104/well) were subsequently 
rechallenged in a proliferation assay with the same EC (104/well) in the 
presence of DAP.3-B7 cells (1:1 ratio). Rechallenge cultures were har- 
vested on days 3, 7, and 10, and3H-TdR was added for the last 18 h. Re- 
suits are expressed as the mean cpm for triplicate cultures XI0  -3, cor- 
rected for background proliferation of both T cells and stimulators alone 
(A cpm). SEs were routinely <10%. The stimulator cells present in the 
initial culture are indicated within each graph. The stimulator cells used in 
the rechallenge step are indicated under each graph. 
sponses.  The inability of EC  to induce primary T  cell re- 
sponses was  overcome by the addition of B7./-expressing 
transfectants,  suggesting that  the EC  were  unable  to  pro- 
vide  costimulation.  Furthermore,  recognition  of alloanti- 
gen  on  the  surface  of EC  induced  nonresponsiveness  in 
resting CD45KA + T  cells. 
The HUVEC  were phenotyped using a variety of mAbs 
specific for EC-specific, accessory, and MHC  class II mole- 
cules. After IFN-~/induction, levels of MHC  class II mole- 
cule expression comparable to that of B-LCL were achieved. 
In addition, the EC  expressed substantial levels of LFA-3 
and  intercellular adhesion  molecule-1.  Most  significantly, 
however, no expression of the B7 family of molecules was 
detected using several anti-B7 reagents. This finding is con- 
sistent with the  contention  that B7  expression is confined 
to specialized, bone marrow-derived APC. 
The capacity of the EC to induce proliferation by the T 
cell  clones  used  in  these  experiments  correlates  with  the 
apparent B7  independence  of the  T  cells.  In  our  experi- 
ence, :'-70% human T  cell clones do not require B7-medi- 
ated costimulation to  secrete  IL-2  (Hargreaves, R.,  et al., 
manuscript in preparation).  Whether B7  dependence cor- 
relates with TCR  avidity, use of an alternative costimula- 
tory pathway or some other feature of the T  cell is unclear 
at the  present time.  The  key issue is the  extent to  which 
secondary  T  cell  responses  are  B7  dependent  in  vivo.  If 
they are not, this would raise the possibility that previously 
activated T  cells may be further activated during the pro- 
cess of transmigration across the EC lining small blood ves- 
sels. This could apply in the context of local inflammation 
when  the EC have been induced to express MHC  class II 
molecules, and may be displaying antigenic peptides at the 
cell surface. 
The failure of EC to induce primary T  cell responses, as 
observed here,  contrasts with  previously published results 
from several groups.  There are at least two possible expla- 
nations for these different results. First, the EC used in the 
experiments described here were depleted of any constitu- 
tively MHC  class II  + cells by magnetic bead depletion, be- 
fore induction of MHC  class II expression with IFN-% It is 
conceivable that primary cultures of EC may contain small 
numbers  of bone  marrow-derived cells, such  as dendritic 
cells (29).  Given the potency of these cells in inducing pri- 
mary T  cell responses, numbers below the limits of detec- 
tion by flow cytometry can have major functional effects. 
Second, differences may exist in the purity of the responder 
T  cell populations. The potential relevance ofT  cell impu- 
rity is illustrated by the finding reported here, that respon- 
siveness to allogeneic EC correlated with responsiveness of 
the T  cells alone to PHA. Given that mitogen responses are 
dependent  on the presence of accessory cells, these results 
suggest that reactivity of naive T  cells to allogeneic EC may 
depend  on  low  level  contamination  of the  responder  T 
cells with accessory cells. 
In  previous  studies,  however,  although  great  care  was 
taken to eliminate MHC  class II-bearing cells from the re- 
sponder T  cell populations, the opposite result was obtained 
(15,  16), The reasons for this discrepancy remain unclear. 
l 610  Endothelial Cells Induce Allospecific Nonresponsiveness The consequence of alloantigen recognition on EC was 
further investigated by measuring the responses  of periph- 
eral blood T  cell subpopulations  expressing the two major 
isoforms ofCD45, CD45R_A, and CD45RO. Neither pop- 
ulation  showed  any significant  proliferation  to  the  MHC 
class II-expressing EC. This led to examination of the con- 
sequences  of alloantigen  recognition  on  EC  for  the  two 
subpopulations  of peripheral  blood T  cells.  For the  RO + 
population, this appeared to be a neutral encounter, in that 
rechallenge with the same EC in the presence of trans co- 
stimulation led to a proliferative response with the kinetics 
of a primary response. This is an unusual occurrence; under 
most circumstances,  specific  recognition  by T  cells  either 
induces activation of an effector function, or leads to some 
form of T  cell silencing.  For the RA  + population, in con- 
trast,  recognition  of alloantigen  presented  by the  EC  in- 
duced  a  marked  state  of reduced  reactivity  to  a  second 
challenge  with  the  same  MHC  alloantigens  expressed  ei- 
ther by the same EC or by a B cell line. 
In  physiological  terms,  these  findings  make  reasonable 
sense.  Resting RA +  T  cells  have  low level  expression  of 
accessory molecules, and T  cells with a given specificity are 
present  in  the  naive  T  cell  repertoire  at  a  very low  fre- 
quency.  As  a  consequence,  it  is  unlikely  that  interactions 
between  MHC  class  II  + EC  and R.A  +  CD4 +  T  cells will 
occur. For previously activated T  cells, either in a resting or 
in a recently activated state,  interactions with activated EC 
may well occur, The outcome of such interactions may ei- 
ther be neutral  or may lead to further activation of the  T 
cell as it enters the inflamed tissue. 
Underlying  all  these  interpretations  are  the  unresolved 
questions as to why EC express MHC class II molecules at all, 
and what are the peptides that they display. One possibility 
is that the EC at the site of inflammation,  once induced to 
express MHC  class  II molecules,  process and present pep- 
tides  derived from the pathogens  causing inflammation in 
the  underlying tissue.  This would create  the  possibility  of 
further activating antigen-specific T  cells as they enter into 
the inflamed tissue.  It is also conceivable that the activated 
EC  acts as  a  "shop window,"  displaying,  in MHC  mole- 
cule-bound peptide form, a sample  of the antigens within 
the  underlying  tissue.  Although  T  cell  recruitment  is 
largely antigen nonspecific, cognate recognition by traffick- 
ing T  cells may allow a degree of specific recruitment. 
Testing the physiological significance of the observations 
made here will require the use of in vivo models. 
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